MEDICINA NUCLEARE - Crosetto Foundation

for imaging small animals 2004 IEEE Nucl. Sci. Symp. Conf. Record (IEEE Cat. No.
04CH37604) pp 3271–4
[130] Mackewn J E, Keevil S F, HallettWA, Halsted P, Page R A, Kelly M,Williams S C R and
Marsden P K 2007 An MR compatible LSO-PET scanner for molecular imaging studies 2006
IEEE Nucl. Sci. Symp. Conf. Record (IEEE Cat. No. 06CH37832) pp 2986–9
[131] McElroy D P, Saveliev V, Reznik A and Rowlands L A 2007 Evaluation of silicon
photomultipliers: a promising new detector for MR compatible PET Nucl. Instrum. Methods
Phys. Res. A 571 106–9
[132] Wagenaar D J, Nalcioglu O, Muftuler L T, Szawlowski M, Kapusta M, Pavlov N, Meier D,
Maehlum G and Patt B E 2007 Development of MRI-compatible nuclear medicine imaging
detectors 2006 IEEE Nucl. Sci. Symp. Conf. Record (IEEE Cat. No. 06CH37832) pp 1825–8
[133] Pichler B J, Judenhofer M S, Catana C,Walton J H, Kneilling M, Nutt R E, Siegel S B,
Claussen C D and Cherry S R 2006 Performance test of an LSO-APD detector in a 7-TMRI
scanner for simultaneous PET/MRI J. Nucl. Med.47 639–47
[134] Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS.Positron emission tomography/magnetic
resonance imaging: the next generation of multimodality imaging? Semin Nucl Med. 2008
May;38(3):199-208. Review.
NUOVI RADIOTRACCIANTI PET
[135] Apolo AB, Pandit-Taskar N, Morris MJ. Novel Tracers and Their Development for the
Imaging of Metastatic Prostate Cancer. J Nucl Med. 2008 Dec;49(12):2031-2041. Epub 2008
Nov 7.
[136] Hospers GA, Helmond FA, de Vries EG, Dierckx RA, de Vries EF. PET imaging of
steroid receptor expression in breast and prostate cancer. Curr Pharm Des.
2008;14(28):3020-32.
[137] Minn H, Grönroos TJ, Komar G, Eskola O, Lehtiö K, Tuomela J, Seppänen M,
SolinO.Imaging of tumor hypoxia to predict treatment sensitivity. Curr Pharm Des.
2008;14(28):2932-42.
[138] Gerstner ER, Sorensen AG, Jain RK, Batchelor TT. Advances in neuroimaging
techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in
gliomas. Curr Opin Neurol. 2008 Dec;21(6):728-35.
[139] Lopci E, Nanni C, Rampin L, Rubello D, Fanti S. Clinical applications of 68Ga-DOTANOC
in neuroendocrine tumours. Minerva Endocrinol. 2008 Sep;33(3):277-81.
[140] Basu S, Kumar R, Rubello D, Fanti S, Alavi A. PET imaging in neuroendocrine tumors:
current status and future prospects. Minerva Endocrinol. 2008 Sep;33(3):257-75.
[141] Lavayssière R, Cabée AE, Filmont JE. Positron Emission Tomography (PET) and breast
cancer in clinical practice. Eur J Radiol. 2008 Sep 22.
[142] McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Khela MK, Aboagye E,
Coombes RC, Hui AM, Cohen PS. The biodistribution and radiation dosimetry of the Arg-Gly-
Asp peptide 18F-AH111585 in healthy volunteers. J Nucl Med. 2008 Oct;49(10):1664-7.
[143] Pantaleo MA, Nannini M, Lopci E, Castellucci P, Maleddu A, Lodi F, Nanni C,Allegri V,
Astorino M, Brandi G, Di Battista M, Boschi S, Fanti S, Biasco G. Molecular imaging and
targeted therapies in oncology: new concepts in treatment response assessment. a collection
of cases. Int J Oncol. 2008 Sep;33(3):443-52.
[144] Blankenberg FG. In vivo detection of apoptosis. J Nucl Med. 2008 Jun;49 Suppl 2:81S-
95S. Review.
[145] Bergstrom M, Monazzam A, Razifar P, Ide S, Josephsson R, Langstrom B. Modeling
spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-
AUY922. J Nucl Med. 2008 Jul;49(7):1204-10. Epub 2008 Jun 13.
[146] Toner GC, Hicks RJ. PET for sarcomas other than gastrointestinal stromal tumors.
Oncologist. 2008;13 Suppl 2:22-6. Review.
[147] Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol. 2008
Jun 15;97(8):649-52. Review.
[148] Bouchelouche K, Oehr P. Recent developments in urologic oncology: positron emission
tomography molecular imaging. Curr Opin Oncol. 2008 May;20(3):321-6. Review.
[149] Kumar R, Dhanpathi H, Basu S, Rubello D, Fanti S, Alavi A. Oncologic PET tracers
beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):50-65. Review.
AIMN - Notiziario elettronico di Medicina Nucleare ed Imaging Molecolare, Anno V, n 2, 2009 pag. 66/85